Osaka, Japan

Masaki Sone

USPTO Granted Patents = 8 

Average Co-Inventor Count = 1.4

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Neyagawa, JP (2009)
  • Osaka, JP (2014 - 2023)

Company Filing History:


Years Active: 2009-2023

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Masaki Sone - Innovator in Photoactivatable Compounds

Introduction

Masaki Sone is an inventor based in Funabashi-shi, Japan. He has made significant contributions to the field of photoactivatable compounds, particularly in the development of caged compounds that can be selectively activated for specific cell types. His innovative approach aims to enhance the precision of bioactive substances in individual organisms.

Latest Patent Applications

Masaki Sone's notable patent application is titled "CAGED COMPOUND WHICH CAN BE PHOTOACTIVATED SELECTIVELY FOR CELL TYPES." The objective of this invention is to provide a caged compound that can be photoactivated selectively for specific target cell types. This compound is represented by the general formula K-Q-X, which is prepared by binding a bioactive substance X, a photocleavable protecting group Q, and a compound K. The compound K can be an enzyme substrate that is dissociated from Q-X through an enzyme reaction. The protecting group Q is designed to be photocleaved by light of a specific wavelength, allowing for the dissociation from X. When Q is bound to X, the substance does not express bioactivity, but once Q is dissociated, X can exhibit its bioactive properties. This innovative approach allows for targeted activation of bioactive substances, enhancing their effectiveness in biological applications.

Conclusion

Masaki Sone's work in developing photoactivatable compounds represents a significant advancement in the field of bioactive substances. His innovative approach has the potential to improve the precision of treatments in various biological contexts.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…